PRC
CMD

Pearl River Capital’s Cantel Medical Corporation CMD Stock Holding History

Pearl River Capital’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-23
Closed -$2K – 935
2018
Q4 		$2K Buy
+23
New +$1.9K 0.01% 795

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Pearl River Capital's CMD Position: Q1 2019 in Review

Pearl River Capital sold out of Cantel Medical Corporation (CMD) in Q1 2019, closing a stake of 23 shares — an estimated $2K sold.

Pearl River Capital first reported a position in CMD in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 254 funds tracked by Wall St. Rank hold CMD as of Q1 2019.

  • Pearl River Capital reported no remaining Cantel Medical Corporation position as of Q1 2019 after selling out during the quarter.
  • Pearl River Capital sold 23 Cantel Medical Corporation shares in Q1 2019, an estimated $2K.
  • Pearl River Capital first reported a position in Cantel Medical Corporation in Q4 2018 and held it in 1 quarter.
  • Pearl River Capital's Cantel Medical Corporation position peaked at $2K in Q4 2018.
  • 254 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2019.

Based on Pearl River Capital's 13F filing for Q1 2019, filed 2 May 2019.